Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
38 participants
OBSERVATIONAL
2014-06-30
2018-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Antibodies to White Blood Cells on Platelet Transfusion Patients
NCT00460122
Use of Blood and Plasma in Norwegian Physician-staffed Helicopter Emergency Medical System
NCT02784951
Effect of Leukoreduced Blood Transfusions on Infection Following Trauma
NCT00135291
Pre-Hospital Use of Plasma for Traumatic Hemorrhage
NCT02303964
Sternal Intraosseous Transfusion of Autologous Whole Blood: A Comparison of Flow Rates and Degree of Hemolysis
NCT02924792
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In-patients will be recruited if receiving plasma transfusion during surgery or if an allergic transfusion complication occurs.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
plasma transfusion
Patients receiving plasma transfusion.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Haukeland University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Torunn O Apelseth, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Helse Bergen HF, Haukeland University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haukeland University Hospital
Bergen, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REK 2014/607
Identifier Type: OTHER
Identifier Source: secondary_id
2014/607
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.